A Double Blind, Double Dummy, Randomised, Multi-centre Study to Assess the Tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan
A Double Blind, Double Dummy, Randomised, Multi-centre Study to Assess the Tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan
To evaluate vildagliptin as compared to gliclazide, given in combination with metformin in Muslim patients with type 2 diabetes fasting during Ramadan.
Inclusion Criteria:
Exclusion Criteria:
"Other protocol-defined inclusion/exclusion criteria may apply"
Santa Coloma de Gramanet, Catalonia 08923, Spain
Le Belvedere - Tunis, Tunisie 1002, Tunisia
Diskapi / Ankara, Turkey 06770, Turkey (Türkiye)